Pacific Biosciences of California, Inc.
PACB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$38 | -$42 | -$426 | $2 |
| Dep. & Amort. | $4 | $5 | $373 | $11 |
| Deferred Tax | $0 | $0 | -$1 | -$0 |
| Stock-Based Comp. | $0 | $0 | $9 | $16 |
| Change in WC | $3 | -$4 | -$2 | $8 |
| Other Non-Cash | $12 | $12 | $3 | -$68 |
| Operating Cash Flow | -$19 | -$29 | -$44 | -$31 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | -$1 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$66 | -$56 | -$62 | -$80 |
| Inv. Sales/Matur. | $85 | $82 | $113 | $140 |
| Other Inv. Act. | $0 | $0 | -$5 | $0 |
| Investing Cash Flow | $19 | $25 | $45 | $58 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $0 | $2 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$51 |
| Financing Cash Flow | $1 | $0 | $2 | -$50 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2 | -$4 | $3 | -$23 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $55 | $59 | $58 | $80 |
| End Cash | $57 | $55 | $61 | $58 |
| Free Cash Flow | -$19 | -$30 | -$50 | -$32 |